Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of antioxidants on oxygen-induced vasoconstriction in LPS-induced inflammatory model in humans
2009-010138-22Phase 4Completed
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of VITAMAC, ascorbic acid, vitamin e, zinc, lutein and 2 more in inflammation, sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoints: Retinal vascular reactivity after LPS administration and Ocular blood flow during inflammation. Started Feb 2009; status: completed.
02
Drugs
VITAMACascorbic acidvitamin ezinclutein
03
Conditions
inflammation
Beyond the preview
Go deeper on 2009-010138-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010138-22.